TCT 838: Clinical Futility in Patients With Active Malignancy Undergoing Trans-Catheter Aortic Valve Replacement After Multidisciplinary Heart Team Decision
Presenter:
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Consultant Fee/Honoraria/Speaker’s Bureau - Abbott Vascular; Abiomed; Medtronic